Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Journal of Clinical Gastroenterology|January 24, 2019
Among Medicare Patients With Hepatocellular Carcinoma, Non-alcoholic Fatty Liver Disease is the Most Common Etiology and Cause of MortalityDanubia Hester, Pegah Golabi, James Paik, et al.Journal of Clinical and Experimental Hepatology|May 10, 2022
Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel SurveyIssah Younossi, Maria Stepanova, Mercedes Walters, et al.Brain and Behavior|November 10, 2012
Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)Aybike Birerdinc, Arian Afendy, Maria Stepanova, et al.The Journal of Infectious Diseases|January 3, 2018
Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free RegimensMaria Stepanova, Alexander Thompson, Joseph Doyle, et al.The American Journal of Managed Care|April 10, 2020
Outcomes of liver transplantation by insurance types in the United StatesMaria Stepanova, Saleh Al Qahtani, Alita Mishra, et al.Transplantation|August 9, 2021
Liver Transplant Center Size and the Impact on Clinical Outcomes and Resource UtilizationSaleh A Alqahtani, Maria Stepanova, Khaled W Kabbara, et al.Alimentary Pharmacology & Therapeutics|November 30, 2019
The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver diseaseJames M Paik, Rati Deshpande, Pegah Golabi, et al.Cancer Medicine|August 18, 2021
The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of lifeManisha Verma, James M Paik, Issah Younossi, et al.Hepatology (Baltimore, Md.)|July 18, 2018
Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource UseMehmet Sayiner, Pegah Golabi, Maria Stepanova, et al.Hepatology (Baltimore, Md.)|April 1, 2022
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?Zobair M Younossi, James M Paik, Reem Al Shabeeb, et al.Pageof 5